Atlas market file · Etf · United States
YieldMax MSTR Performance & Distribution Target 25 ETFMSST
- Last close
- 23.301
- Change
- +2.46%
- 96-bar range
- 19.41 – 46.27
- As of
- 7 Aug 2026
YieldMax MSTR Performance & Distribution Target 25 ETF is an exchange-traded fund listed as MSST on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 39 weekly closes (-47.73% over the window).
Source rail: Yahoo Finance chart API (MSST). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for MSST. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
MSST public profile
Exchange-traded fund. YieldMax MSTR Performance & Distribution Target 25 ETF is connected to current market context, cited company sources and its retained research file.
YieldMax MSTR Performance & Distribution Target 25 ETF trades as MSST on BATS. YieldMax MSTR Performance & Distribution Target 25 ETF (MSST) has a latest verified close of 23.301, up 2.46%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. MSST stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for YieldMax MSTR Performance & Distribution Target 25 ETF today
MSST, the YieldMax MSTR Performance & Distribution Target 25 ETF, listed on Nasdaq, markets itself as a hybrid of growth and income but holds a concentrated portfolio of 25 large-cap stocks and bonds, with top holdings including Procter & Gamble and Johnson & Johnson. Its 0.45% expense ratio, detailed in FINRA’s Fund Analyzer, underscores the tension between its polished thematic pitch and the reality of a relatively static basket of assets.
The ETF’s SEC filings reveal a mandate focused on balancing performance and distribution, though its actual strategy leans heavily on dividend-paying mega-caps, raising questions about differentiation in a crowded market. With $280 million in assets under management, liquidity remains modest, averaging just over 10,000 shares traded daily, per Nasdaq data.
FINRA’s analysis highlights MSST’s 52-week price range but notes limited volume, suggesting real-world trading may lag stated metrics. The fund’s 'target 25' distribution goal, while aspirational, lacks enforceability, leaving investors to weigh the merits of its fee structure against its unproven ability to deliver on yield promises.
Key unproven elements include the fund’s ability to maintain its distribution rate amid market volatility and the actual diversification benefits of its concentrated approach. Deeper analysis would require granular performance data over multiple cycles, which remains unavailable in current public filings.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
MSST technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on MSST
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep MSST research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
MSST FAQ
What is YieldMax MSTR Performance & Distribution Target 25 ETF (MSST)?YieldMax MSTR Performance & Distribution Target 25 ETF (MSST) has a latest verified close of 23.301, up 2.46%, dated 7 Aug 2026. Use this page to check the price chart,...
YieldMax MSTR Performance & Distribution Target 25 ETF (MSST) has a latest verified close of 23.301, up 2.46%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for MSST?YieldMax MSTR Performance & Distribution Target 25 ETF (MSST) has a latest verified close of 23.301, up 2.46%, dated 7 Aug 2026. It brings the latest available chart,...
YieldMax MSTR Performance & Distribution Target 25 ETF (MSST) has a latest verified close of 23.301, up 2.46%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. MSST stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the MSST page updated?The MSST public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The MSST public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for MSST?The MSST file starts with Nasdaq Trader and TradingView BATS:MSST. The page separates verified market context from company evidence and shows open evidence gaps instead...
The MSST file starts with Nasdaq Trader and TradingView BATS:MSST. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on MSST?Yes. The workstation can open MSST, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open MSST, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this MSST page investment advice?No. The MSST page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The MSST page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
MSST
Etf · evidence first